一级亲属1型糖尿病儿童及成人中根据自身抗体谱、年龄和HLA-DQ基因型评估的20年临床发病进展率
比利时糖尿病登记处对462例40岁以下、持续胰岛自身抗体阳性的1型糖尿病患者一级亲属随访20年。多抗体阳性者20年进展率88%,高于单抗体阳性者的54%(P < 0.001);IA-2A或ZnT8A是多抗体阳性者更快进展的唯一独立预测因素(P < 0.001)。
要点
- 多抗体阳性亲属20年进展率88%,高于单抗体阳性者的54%(P < 0.001)。
- 多抗体阳性者中,IA-2A或ZnT8A是更快进展的唯一独立预测因素(P < 0.001)。
- 单抗体阳性者中,较年轻年龄、HLA-DQ2/DQ8基因型和IAA为多抗体阳转的独立预测因素。
核心结论
- 单抗体阳性亲属中,进展至多抗体阳性的时间随年龄增长、IAA缺失和HLA-DQ2/DQ8基因型缺失而延长。
- 多数多抗体阳性个体在20年内进展为糖尿病;携带IA-2A或ZnT8A者进展更快,与年龄、HLA-DQ基因型和自身抗体数量无关。
- 这些数据可能有助于细化症状前1型糖尿病的风险分层。
研究设计与样本
- 比利时糖尿病登记处对持续胰岛自身抗体阳性的1型糖尿病患者一级亲属(兄弟姐妹和子代,n = 462,40岁以下)进行随访。
- 采用放射结合法测定胰岛素(IAA)、GAD(GADA)、IA-2抗原(IA-2A)和锌转运体8(ZnT8A)自身抗体。
主要发现
- 多抗体阳性亲属(n = 194)20年进展率为88%,高于单抗体阳性者(n = 268)的54%(P < 0.001)。
- IAA和GADA双阳性亲属(n = 54)进展慢于携带IA-2A和/或ZnT8A的双抗体阳性个体(n = 38;P = 0.001)。
- 多抗体阳性亲属中,Cox回归分析显示IA-2A或ZnT8A的存在是更快进展至糖尿病的唯一独立预测因素(P < 0.001)。
- 单抗体阳性亲属中,Cox回归分析显示较年轻年龄(P < 0.001)、HLA-DQ2/DQ8基因型(P < 0.001)和IAA(P = 0.028)为多抗体阳转的独立预测因素。
- 时依Cox回归中,较年轻年龄(P = 0.042)、HLA-DQ2/DQ8基因型(P = 0.009)和额外自身抗体的出现(P = 0.012)与更快进展至糖尿病相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We investigated whether islet autoantibody profile, HLA-DQ genotype, and age influenced a 20-year progression to diabetes from first autoantibody positivity (autoAb+) in first-degree relatives of patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: Persistently islet autoAb+ siblings and offspring (n = 462) under 40 years of age were followed by the Belgian Diabetes Registry. AutoAbs against insulin (IAA), GAD (GADA), IA-2 antigen (IA-2A), and zinc transporter 8 (ZnT8A) were determined by radiobinding assay. RESULTS: The 20-year progression rate of multiple-autoAb+ relatives (n = 194) was higher than that for single-autoAb+ participants (n = 268) (88% vs. 54%; P < 0.001). Relatives positive for IAA and GADA (n = 54) progressed more slowly than double-autoAb+ individuals carrying IA-2A and/or ZnT8A (n = 38; P = 0.001). In multiple-autoAb+ relatives, Cox regression analysis identified the presence of IA-2A or ZnT8A as the only independent predictors of more rapid progression to diabetes (P < 0.001); in single-autoAb+ relatives, it identified younger age (P < 0.001), HLA-DQ2/DQ8 genotype (P < 0.001), and IAA (P = 0.028) as independent predictors of seroconversion to multiple positivity for autoAbs. In time-dependent Cox regression, younger age (P = 0.042), HLA-DQ2/DQ8 genotype (P = 0.009), and the development of additional autoAbs (P = 0.012) were associated with more rapid progression to diabetes. CONCLUSIONS: In single-autoAb+ relatives, the time to multiple-autoAb positivity increases with age and the absence of IAA and HLA-DQ2/DQ8 genotype. The majority of multiple-autoAb+ individuals progress to diabetes within 20 years; this occurs more rapidly in the presence of IA-2A or ZnT8A, regardless of age, HLA-DQ genotype, and number of autoAbs. These data may help to refine the risk stratification of presymptomatic type 1 diabetes.
引用
- Gorus FK, Balti EV, Messaaoui A, et al. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes. Diabetes Care. 2017. PMID: 28701370. doi:10.2337/dc16-2228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。